Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

PRINCIPLE Trial Collaborative Group, View ORCID ProfileJienchi Dorward, View ORCID ProfileLy-Mee Yu, View ORCID ProfileGail Hayward, Benjamin R Saville, View ORCID ProfileOghenekome Gbinigie, View ORCID ProfileOliver Van Hecke, View ORCID ProfileEmma Ogburn, View ORCID ProfilePhilip H Evans, View ORCID ProfileNicholas PB Thomas, View ORCID ProfileMahendra G Patel, View ORCID ProfileDuncan Richards, View ORCID ProfileNicholas Berry, View ORCID ProfileMichelle A Detry, View ORCID ProfileChristina Saunders, View ORCID ProfileMark Fitzgerald, View ORCID ProfileVictoria Harris, View ORCID ProfileMilensu Shanyinde, View ORCID ProfileSimon de Lusignan, View ORCID ProfileMonique I Andersson, View ORCID ProfileChristopher C Butler, View ORCID ProfileFD Richard Hobbs
doi: https://doi.org/10.1101/2021.09.20.21263828
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Jienchi Dorward
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
2Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa
Roles: clinical research fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jienchi Dorward
Ly-Mee Yu
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Roles: associate professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ly-Mee Yu
Gail Hayward
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Roles: associate professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gail Hayward
Benjamin R Saville
3Berry Consultants, Texas, USA
4Department of Biostatistics, Vanderbilt University School of Medicine, Tennessee, USA
Roles: statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oghenekome Gbinigie
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Roles: clinical research fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oghenekome Gbinigie
Oliver Van Hecke
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Roles: academic clinical lecturer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oliver Van Hecke
Emma Ogburn
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Roles: director of operations
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emma Ogburn
Philip H Evans
5College of Medicine and Health, University of Exeter, Exeter, UK
6National Institute for Health Research (NIHR) Clinical Research Network, National Institute for Health Research, London, UK
Roles: associate professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philip H Evans
Nicholas PB Thomas
6National Institute for Health Research (NIHR) Clinical Research Network, National Institute for Health Research, London, UK
7Royal College of General Practitioners, London, UK
Roles: general practitioner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas PB Thomas
Mahendra G Patel
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Roles: professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mahendra G Patel
Duncan Richards
8Oxford Clinical Trials Research Unit, Botnar Research Centre, University of Oxford, UK
Roles: professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Duncan Richards
Nicholas Berry
3Berry Consultants, Texas, USA
Roles: statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas Berry
Michelle A Detry
3Berry Consultants, Texas, USA
Roles: statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michelle A Detry
Christina Saunders
3Berry Consultants, Texas, USA
Roles: statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christina Saunders
Mark Fitzgerald
3Berry Consultants, Texas, USA
Roles: statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Fitzgerald
Victoria Harris
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Roles: statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Victoria Harris
Milensu Shanyinde
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Roles: statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Milensu Shanyinde
Simon de Lusignan
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
7Royal College of General Practitioners, London, UK
Roles: professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon de Lusignan
Monique I Andersson
9Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Roles: consultant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Monique I Andersson
Christopher C Butler
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Roles: professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher C Butler
  • For correspondence: principle@phc.ox.ac.uk
FD Richard Hobbs
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Roles: professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for FD Richard Hobbs
  • For correspondence: principle@phc.ox.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Colchicine has been proposed as a COVID-19 treatment, but its effect on time to recovery is unknown. We aimed to determine whether colchicine is effective at reducing time to recovery and COVID-19 related hospitalisations/deaths among people in the community.

Design Prospective, multicentre, open-label, multi-arm, adaptive Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE).

Setting National trial run remotely from a central trial site and at multiple primary care centres across the United Kingdom.

Participants Adults aged ≥65, or ≥18 years with comorbidities or shortness of breath, and unwell ≤14 days with suspected COVID-19 in the community.

Interventions Participants were randomised to usual care, usual care plus colchicine (500µg daily for 14 days), or usual care plus other interventions.

Main outcome measures The co-primary endpoints were time to first self-reported recovery, and hospitalisation/death related to COVID-19, within 28 days, analysed using Bayesian models. The hypothesis for the time to recovery endpoint is evaluated first, and if superiority is declared on time to recovery, the hypothesis for the second co-primary endpoint of hospitalisation/death is then evaluated. To determine futility, we pre-specified a clinically meaningful benefit in time to first reported recovery as a hazard ratio of 1.2 or larger (equating to approximately 1.5 days benefit in the colchicine arm, assuming 9 days recovery in the usual care arm).

Results The trial opened on April 2, 2020, with randomisation to colchicine starting on March 04, 2021 and stopping on May 26, 2021, because the pre-specified time to recovery futility criterion was met. The primary analysis model included 2755 SARS-CoV-2 positive participants, randomised to colchicine (n=156), usual care (n=1145), and other treatments (n=1454). Time to first self-reported recovery was similar in the colchicine group compared with usual care with an estimated hazard ratio of 0.919 [95% credible interval 0.72 to 1.16] and an estimated increase of 1.14 days [−1.86 to 5.21] in median time to self-reported recovery for colchicine versus usual care. The probability of meaningful benefit in time to recovery was very low at 1.8%. Results were similar in comparisons with concurrent controls. COVID-19 related hospitalisations/deaths were similar in the colchicine group versus usual care, with an estimated odds ratio of 0.76 [0.28 to 1.89] and an estimated difference of −0.4% [−2.7% to 2.4]. One serious adverse event occurred in the colchicine group and one in usual care.

Conclusions Colchicine did not improve time to recovery in people at higher risk of complications with COVID-19 in the community.

Trial registration ISRCTN86534580.

Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/disclosure-of-interest/ and declare: Drs. Saville, Berry, Detry, Fitzgerald and Saunders report grants from The University of Oxford, for the Sponsor's grant from the UK NIHR, for statistical design and analyses for the PRINCIPLE trial during the conduct of the study. Prof de Lusignan is Director of the Oxford-RCGP Research and Surveillance Centre and reports that through his University he has had grants outside the submitted work from AstraZeneca, GSK, Sanofi, Seqirus and Takeda for vaccine related research, and membership of advisory boards for AstraZeneca, Sanofi and Seqirus. Dr. Andersson reports grants from Prenetics and Pfizer and personal fees from Prenetics, outside the submitted work. Profs Hobbs and Butler reports grants from UKRI, during the conduct of the study. All other authors have no competing interests to declare.

Clinical Trial

ISRCTN86534580

Clinical Protocols

https://www.principletrial.org

https://bmjopen.bmj.com/content/11/6/e046799

Funding Statement

The PRINCIPLE trial is funded by a grant to the University of Oxford from UK Research and Innovation and the Department of Health and Social Care through the National Institute for Health Research as part of the UK Government rapid research response fund. The views expressed are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the UK Medicines and Healthcare products Regulatory Agency and the South Central-Berkshire Research Ethics Committee (Ref: 20/SC/0158).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵¶ Writing committee listed below on behalf of the PRINCIPLE Trial Collaborative Group. PRINCIPLE trial collaborators are listed in the appendix

Data Availability

Data can be shared with qualifying researchers who submit a proposal with a valuable research question as assessed by a committee formed from the TMG including senior statistical and clinical representation. A contract should be signed.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted September 23, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
PRINCIPLE Trial Collaborative Group, Jienchi Dorward, Ly-Mee Yu, Gail Hayward, Benjamin R Saville, Oghenekome Gbinigie, Oliver Van Hecke, Emma Ogburn, Philip H Evans, Nicholas PB Thomas, Mahendra G Patel, Duncan Richards, Nicholas Berry, Michelle A Detry, Christina Saunders, Mark Fitzgerald, Victoria Harris, Milensu Shanyinde, Simon de Lusignan, Monique I Andersson, Christopher C Butler, FD Richard Hobbs
medRxiv 2021.09.20.21263828; doi: https://doi.org/10.1101/2021.09.20.21263828
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
PRINCIPLE Trial Collaborative Group, Jienchi Dorward, Ly-Mee Yu, Gail Hayward, Benjamin R Saville, Oghenekome Gbinigie, Oliver Van Hecke, Emma Ogburn, Philip H Evans, Nicholas PB Thomas, Mahendra G Patel, Duncan Richards, Nicholas Berry, Michelle A Detry, Christina Saunders, Mark Fitzgerald, Victoria Harris, Milensu Shanyinde, Simon de Lusignan, Monique I Andersson, Christopher C Butler, FD Richard Hobbs
medRxiv 2021.09.20.21263828; doi: https://doi.org/10.1101/2021.09.20.21263828

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1435)
  • Dentistry and Oral Medicine (220)
  • Dermatology (158)
  • Emergency Medicine (293)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10335)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2656)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (682)
  • Hematology (269)
  • HIV/AIDS (571)
  • Infectious Diseases (except HIV/AIDS) (12119)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2484)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (497)
  • Occupational and Environmental Health (569)
  • Oncology (1335)
  • Ophthalmology (403)
  • Orthopedics (153)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (786)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2422)
  • Public and Global Health (5032)
  • Radiology and Imaging (902)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)